1-1 of 1
Guus van Dongen
Close
Sort by
Journal Articles

No Harmful Impact of 90Yttrium-Ibritumomab Tiuxetan Combined with BEAM On Bone Marrow Microenvironment.

Otto Visser, MD, Floortje Kessler, Lars Perk, Maria Vosjan, Guus van Dongen, JoseĢe Zijlstra, MD, PhD, Peter Huijgens, MD, PhD, Sonja Zweegman, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3538.
https://doi.org/10.1182/blood.V114.22.3538.3538
Published: 2009